Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSamuel Cheshier, Abdullah H. Feroze, Jie Liu et al.|Science Translational Medicine|2017Cited by 427
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blockerTomás A. Martins, Gregor Hütter|Nature Communications|2024Cited by 37
Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not peripheryTala Shekarian, Gregor Hütter|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 8